查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1887032

微创手术器材市场规模、占有率、成长及全球产业分析：依类型、应用和地区划分的洞察，以及2024年至2032年的预测

Minimally Invasive Surgery Devices Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 200 Pages | 商品交期: 请询问到货日

价格

微创手术 (MIS) 器械市场成长驱动因素

随着医疗保健系统转向能够缩短恢復时间、最大限度减少创伤并提高手术精准度的手术方式，全球微创手术器械市场持续增长。根据2024年的产业估值，2024年微创手术器械市场规模将达到190.7亿美元，这主要得益于心臟病学、骨科、妇科和胃肠病学等专科领域对微创手术的日益普及。预计到2025年，该市场规模将达到202.7亿美元，并在2032年显着增长至349.3亿美元，2025年至2032年的复合年增长率（CAGR）为8.1%。

微创手术（MIS）器械，包括腹腔镜器械、内视镜、机器人辅助系统、扩张器械、导航系统和专用手术器械，使外科医生能够透过小切口或自然孔道进行复杂的手术，从而减轻患者的疼痛、感染风险并缩短住院时间。

北美将在2024年引领市场

2024年，北美持续维持在全球微创手术器械市场的领先地位，占40.27%的市场占有率（价值76.8亿美元）。这一优势归功于其完善的医疗基础设施、高手术量、机器人手术的广泛应用以及对微创手术有利的报销政策。预计到 2024 年，美国将拥有超过 6,300 家获得联邦医疗保险 (Medicare) 认证的门诊手术中心 (ASC)，这将持续推动该地区对腹腔镜和机器人手术解决方案的需求。

市场规模概览 (2024-2032)

  • 2024 年：190.7 亿美元
  • 2025 年：202.7 亿美元
  • 2032 年：349.3 亿美元

由于慢性病发生率上升、人口老化以及外科技术的进步，市场持续扩张。

主要国家亮点

美国

美国在骨科、心臟病学和胃肠病学领域的微创手术量方面处于世界领先地位。广泛的保险覆盖、主流手术机器人的普及以及美敦力、强生和直觉外科等公司的强大影响力，都支撑着美国市场的强劲势头。

日本

人口老化和对机器人技术的大力投资正在推动机器人辅助腹腔镜和内视镜手术的快速普及。医院和学术机构正扩大采用新一代微创手术平台。

中国

截至2023年，60岁及以上人口将达到2.97亿，慢性病盛行率的持续上升正在推动对微创手术的需求。对机器人平台的投资和三级医院的扩建正在支持微创手术的广泛应用。

欧洲

机器人辅助手术在英国和德国等国家正迅速普及。英国首例儿科机器人手术于2025年初完成，这反映了该地区先进的外科创新能力。

市场动态

驱动因素－慢性疾病日益增多

心血管疾病、癌症、糖尿病和肥胖等慢性疾病正在推动微创手术（MIS）数量的成长。根据英国心臟基金会（2025年）统计，全球有6.2亿人患有心臟和循环系统疾病，因此对微创治疗的需求持续增加。全球每年进行超过400万例膝关节镜手术，凸显了骨科领域对微创手术的庞大需求。

限制因素－微创手术技术成本高

先进的微创手术工具，尤其是机器人系统，需要大量投资。像达文西手术系统这样的设备售价约为200万美元，还不包括维护和培训费用，这限制了其在小型医院和乡村医院的普及。

机会－门诊手术中心的成长

到2024年，美国将拥有超过6300家获得联邦医疗保险认证的门诊手术中心，大量微创手术转移到门诊进行，这催生了对影像导航微创手术器械的强劲需求。

挑战－熟练外科医生短缺

仅在美国，预计到2036年，外科医生缺口将达到15800至30200人，这将影响微创手术能力，并减缓其在全球范围内的普及。

市场趋势

包括机器人辅助平台、人工智慧引导工具、3D视觉化和微型内视镜在内的技术进步，不断重新定义微创手术 (MIS) 的标准。美敦力公司向美国食品药物管理局 (FDA) 提交的 Hugo RAS 系统申请、直觉外科公司达文西 5 系统于 2024 年获批，以及单孔手术的创新，都显示了该领域的快速发展。

近期趋势包括：

  • 2025 年 4 月：美敦力公司扩大泌尿科机器人手术的临床试验。
  • 2024 年 3 月：直觉外科公司的达文西 5 系统获得 FDA 批准。
  • 2023-2024 年：史赛克公司推出新型微创手术探针与 1788 微创手术摄影平台。

微创外科器械市场成长驱动因素

随着医疗系统朝向能够缩短恢復时间、减少创伤并提高手术精准度的手术方式转型，全球微创外科器械市场持续成长。根据2024年的产业估值，微创外科器械市场规模预计将达到190.7亿美元，这主要得益于心臟病学、骨科、妇科和胃肠病学等专科领域对微创手术的日益普及。预计到2025年，市场规模将达到202.7亿美元，并在2032年显着增长至349.3亿美元，2025年至2032年的复合年增长率（CAGR）为8.1%。

微创手术（MIS）器械，包括腹腔镜器械、内视镜、机器人辅助系统、扩张器械、导航系统和专用手术器械，使外科医生能够透过小切口或自然孔道进行复杂的手术，从而减轻患者的疼痛、感染风险并缩短住院时间。

北美将在2024年引领市场

2024年，北美持续维持在全球微创手术器械市场的领先地位，占40.27%的市场占有率（价值76.8亿美元）。这一主导地位归功于其完善的医疗基础设施、高手术量、机器人手术的广泛应用以及对微创手术有利的报销政策。预计到 2024 年，美国将拥有超过 6,300 家获得联邦医疗保险 (Medicare) 认证的门诊手术中心 (ASC)，这将持续推动该地区对腹腔镜和机器人手术解决方案的需求。

市场规模概览 (2024-2032)

  • 2024 年：190.7 亿美元
  • 2025 年：202.7 亿美元
  • 2032 年：349.3 亿美元

由于慢性病发生率上升、人口老化以及外科技术的进步，市场持续扩张。

主要国家亮点

美国

美国在骨科、心臟病学和胃肠病学领域的微创手术量方面处于世界领先地位。美国市场的强劲势头得益于广泛的保险覆盖、主流手术机器人的普及以及美敦力、强生和直觉外科等公司的强大影响力。

日本

人口老化和对机器人技术的大力投资正在推动机器人辅助腹腔镜和内视镜手术的快速普及。医院和学术机构正扩大采用新一代微创手术平台。

中国

到2023年，60岁以上人口将达到2.97亿，慢性病盛行率的持续上升将推动对微创手术的需求。对机器人平台的投资和三级医疗机构的扩建支持了微创手术的广泛应用。

欧洲

机器人辅助手术在英国和德国等国家正迅速普及。英国首例儿科机器人手术于2025年初完成，这反映了该地区先进的外科创新能力。

市场动态

驱动因素－慢性疾病日益增多

心血管疾病、癌症、糖尿病和肥胖等慢性疾病正在推动微创手术（MIS）数量的成长。鑑于全球有6.2亿人患有心臟和循环系统疾病（英国心臟基金会，2025），对微创治疗的需求持续成长。全球每年进行超过400万例膝关节镜手术，凸显了骨科领域对微创手术的巨大需求。

限制因素－微创手术技术成本高

先进的微创手术工具，尤其是机器人系统，需要大量投资。像达文西手术系统这样的设备造价约为 200 万美元，还不包括维护和培训费用，这限制了其在小型和区域性医院的普及。

机会－门诊手术中心成长

截至 2024 年，美国已有超过 6300 家获得联邦医疗保险认证的门诊手术中心，大量微创手术转移到门诊进行，这催生了对影像导航微创手术器械的强劲需求。

挑战－熟练外科医生短缺

仅在美国，预计到 2036 年外科医生缺口就将达到 15800 至 30200 人，这将影响微创手术能力，并减缓其在全球范围内的普及。

市场趋势

包括机器人辅助平台、人工智慧引导工具、3D视觉化和微型内视镜在内的技术进步，不断重新定义微创手术 (MIS) 的标准。美敦力公司向美国食品药物管理局 (FDA) 提交的 Hugo RAS 系统申请、直觉外科公司达文西 5 系统于 2024 年获批，以及单孔手术的创新，都显示了该领域的快速发展。

近期进展包括：

  • 2025 年 4 月：美敦力公司扩大泌尿科机器人手术的临床试验。
  • 2024 年 3 月：直觉外科公司的达文西 5 系统获得 FDA 批准。
  • 2023-2024 年：史赛克公司推出新型微创手术探针与 1788 MIS 摄影机平台。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：主要发现

  • 主要国家和地区的主要手术量（2024 年）
  • 主要产业趋势－併购、合作及其他
  • 概述：监管和报销情况
  • 主要公司的新产品发布

第五章：全球微创手术器材市场分析、洞察与预测（2019-2032）

  • 市场分析、洞察与预测 - 依类型划分
    • 充气装置
    • 引导装置
    • 内视镜装置
    • 腹腔镜装置
    • 机器人辅助手术装置
    • 导航视觉化系统
    • 其他
  • 市场分析、洞察与预测 - 依应用领域划分
    • 心臟病学
    • 胃肠病学
    • 骨科
    • 妇科
    • 神经病学
    • 牙科
    • 其他
  • 市场分析、洞察与预测 - 依最终用户划分
    • 医院及门诊手术中心
    • 诊所
    • 其他
  • 市场分析、洞察与预测 - 依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章 北美微创外科器械市场分析、洞察与预测 （2019-2032）

  • 依国家划分
    • 美国
    • 加拿大

第七章：欧洲微创外科器材市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪的纳维亚
    • 欧洲其他地区

第八章：亚太地区微创外科器械市场分析、洞察与预测（2019-2032）

  • 依国家/地区
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 东南亚
    • 亚太其他地区

第九章：拉丁美洲微创手术器材市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

第十章：中东与非洲微创手术器材市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 海湾合作委员会
    • 南非
    • 中东其他地区非洲

第十一章 竞争分析

  • 全球市占率分析（2024）
  • 公司简介
    • 美敦力公司
    • 强生服务公司
    • 皇家飞利浦公司
    • 波士顿科学公司
    • 奥林巴斯公司
    • 史赛克公司
    • 贝朗公司
    • 史特瑞斯公司
    • 直觉外科公司
Product Code: FBI113274

Growth Factors of minimally invasive surgery (MIS) devices Market

The global minimally invasive surgery (MIS) devices market continues to gain momentum as healthcare systems increasingly shift toward procedures that reduce recovery time, minimize trauma, and enhance surgical precision. According to the 2024 industry assessment, the MIS devices market was valued at USD 19.07 billion in 2024, driven by rising adoption of MIS procedures across cardiology, orthopedics, gynecology, and gastrointestinal specialties. The market is expected to reach USD 20.27 billion in 2025 and expand significantly to USD 34.93 billion by 2032, exhibiting a strong CAGR of 8.1% from 2025 to 2032.

MIS devices-including laparoscopic tools, endoscopes, robotic-assisted systems, inflation devices, navigation systems, and specialized surgical instruments-enable surgeons to perform complex interventions through small incisions or natural orifices, reducing pain, infection risk, and hospital stays.

North America Leads the Market in 2024

North America dominated the global minimally invasive surgery devices market in 2024 with a 40.27% share, equivalent to USD 7.68 billion. This leadership stems from well-established healthcare infrastructure, high surgical volumes, widespread robotic surgery adoption, and favorable reimbursement policies for MIS procedures. The U.S., with more than 6,300 Medicare-certified Ambulatory Surgical Centers (ASCs) by 2024, continues to drive regional demand for laparoscopic and robotic solutions.

Market Size Overview (2024-2032)

  • 2024: USD 19.07 billion
  • 2025: USD 20.27 billion
  • 2032: USD 34.93 billion

The combination of rising chronic disease incidence, aging populations, and advancements in surgical technologies continues to propel the market forward.

Key Country Highlights

United States

The U.S. leads globally in MIS procedure volume across orthopedic, cardiology, and gastrointestinal applications. Extensive insurance coverage, major surgical robot installations, and strong presence of Medtronic, Johnson & Johnson, and Intuitive Surgical fuel U.S. market strength.

Japan

An aging population and strong robotics investment drive rapid adoption of robotic-assisted laparoscopic and endoscopic surgeries. Hospitals and academic centers increasingly integrate next-generation MIS platforms.

China

With 297 million individuals aged 60+ in 2023, chronic conditions continue to rise, driving MIS demand. Investments in robotic platforms and expanding tertiary care hospitals support broad MIS adoption.

Europe

Countries such as the U.K. and Germany show strong momentum in robotic-assisted surgeries. The U.K.'s first pediatric robotic surgery in early 2025 reflects the region's advanced surgical innovation capabilities.

Market Dynamics

Drivers - Rising Chronic Conditions

Chronic diseases such as cardiovascular disorders, cancer, diabetes, and obesity are driving MIS procedure volumes. With 620 million people worldwide living with heart and circulatory diseases (British Heart Foundation, 2025), the need for minimally invasive interventions continues expanding. Globally, over 4 million arthroscopic knee surgeries are performed annually, highlighting high orthopedic MIS demand.

Restraints - High Cost of MIS Technologies

Advanced MIS tools-especially robotic systems-require heavy investment. Systems like the Da Vinci Surgical System cost around USD 2 million, excluding maintenance and training, limiting adoption in smaller and rural hospitals.

Opportunities - Growth of Ambulatory Surgical Centers

With 6,300+ Medicare-certified ASCs in the U.S. (2024), the shift of high-volume MIS procedures to outpatient settings creates strong demand for imaging, navigation, and minimally invasive tools.

Challenges - Shortage of Skilled Surgeons

The U.S. alone faces a projected shortage of 15,800-30,200 surgeons by 2036, affecting MIS capacity and slowing global adoption.

Market Trends

Technological advancements-including robotic-assisted platforms, AI-guided tools, 3D visualization, and miniaturized endoscopes-continue to redefine MIS standards. Medtronic's FDA submission of the Hugo RAS system, Intuitive Surgical's da Vinci 5 clearance in 2024, and innovations in single-port surgery demonstrate the rapid evolution of the field.

Competitive Landscape

The market is dominated by industry leaders such as:

  • Medtronic
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips N.V.
  • Stryker
  • Olympus Corporation
  • Boston Scientific
  • Intuitive Surgical

These companies drive innovation through new launches, AI-integrated surgical solutions, and expansions in robotic surgery systems.

Recent developments include:

  • April 2025: Medtronic expands its URO robotic surgery clinical trial.
  • March 2024: Intuitive receives FDA clearance for da Vinci 5.
  • 2023-2024: Stryker introduces new minimally invasive surgical probe and 1788 MIS camera platform.

Growth Factors of minimally invasive surgery (MIS) devices Market

The global minimally invasive surgery (MIS) devices market continues to gain momentum as healthcare systems increasingly shift toward procedures that reduce recovery time, minimize trauma, and enhance surgical precision. According to the 2024 industry assessment, the MIS devices market was valued at USD 19.07 billion in 2024, driven by rising adoption of MIS procedures across cardiology, orthopedics, gynecology, and gastrointestinal specialties. The market is expected to reach USD 20.27 billion in 2025 and expand significantly to USD 34.93 billion by 2032, exhibiting a strong CAGR of 8.1% from 2025 to 2032.

MIS devices-including laparoscopic tools, endoscopes, robotic-assisted systems, inflation devices, navigation systems, and specialized surgical instruments-enable surgeons to perform complex interventions through small incisions or natural orifices, reducing pain, infection risk, and hospital stays.

North America Leads the Market in 2024

North America dominated the global minimally invasive surgery devices market in 2024 with a 40.27% share, equivalent to USD 7.68 billion. This leadership stems from well-established healthcare infrastructure, high surgical volumes, widespread robotic surgery adoption, and favorable reimbursement policies for MIS procedures. The U.S., with more than 6,300 Medicare-certified Ambulatory Surgical Centers (ASCs) by 2024, continues to drive regional demand for laparoscopic and robotic solutions.

Market Size Overview (2024-2032)

  • 2024: USD 19.07 billion
  • 2025: USD 20.27 billion
  • 2032: USD 34.93 billion

The combination of rising chronic disease incidence, aging populations, and advancements in surgical technologies continues to propel the market forward.

Key Country Highlights

United States

The U.S. leads globally in MIS procedure volume across orthopedic, cardiology, and gastrointestinal applications. Extensive insurance coverage, major surgical robot installations, and strong presence of Medtronic, Johnson & Johnson, and Intuitive Surgical fuel U.S. market strength.

Japan

An aging population and strong robotics investment drive rapid adoption of robotic-assisted laparoscopic and endoscopic surgeries. Hospitals and academic centers increasingly integrate next-generation MIS platforms.

China

With 297 million individuals aged 60+ in 2023, chronic conditions continue to rise, driving MIS demand. Investments in robotic platforms and expanding tertiary care hospitals support broad MIS adoption.

Europe

Countries such as the U.K. and Germany show strong momentum in robotic-assisted surgeries. The U.K.'s first pediatric robotic surgery in early 2025 reflects the region's advanced surgical innovation capabilities.

Market Dynamics

Drivers - Rising Chronic Conditions

Chronic diseases such as cardiovascular disorders, cancer, diabetes, and obesity are driving MIS procedure volumes. With 620 million people worldwide living with heart and circulatory diseases (British Heart Foundation, 2025), the need for minimally invasive interventions continues expanding. Globally, over 4 million arthroscopic knee surgeries are performed annually, highlighting high orthopedic MIS demand.

Restraints - High Cost of MIS Technologies

Advanced MIS tools-especially robotic systems-require heavy investment. Systems like the Da Vinci Surgical System cost around USD 2 million, excluding maintenance and training, limiting adoption in smaller and rural hospitals.

Opportunities - Growth of Ambulatory Surgical Centers

With 6,300+ Medicare-certified ASCs in the U.S. (2024), the shift of high-volume MIS procedures to outpatient settings creates strong demand for imaging, navigation, and minimally invasive tools.

Challenges - Shortage of Skilled Surgeons

The U.S. alone faces a projected shortage of 15,800-30,200 surgeons by 2036, affecting MIS capacity and slowing global adoption.

Market Trends

Technological advancements-including robotic-assisted platforms, AI-guided tools, 3D visualization, and miniaturized endoscopes-continue to redefine MIS standards. Medtronic's FDA submission of the Hugo RAS system, Intuitive Surgical's da Vinci 5 clearance in 2024, and innovations in single-port surgery demonstrate the rapid evolution of the field.

Competitive Landscape

The market is dominated by industry leaders such as:

  • Medtronic
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips N.V.
  • Stryker
  • Olympus Corporation
  • Boston Scientific
  • Intuitive Surgical

These companies drive innovation through new launches, AI-integrated surgical solutions, and expansions in robotic surgery systems.

Recent developments include:

  • April 2025: Medtronic expands its URO robotic surgery clinical trial.
  • March 2024: Intuitive receives FDA clearance for da Vinci 5.
  • 2023-2024: Stryker introduces new minimally invasive surgical probe and 1788 MIS camera platform.

Segmentation By Type

  • Inflation Devices
  • Guiding Devices
  • Endoscopic Devices
  • Laparoscopic Devices
  • Robotic Assistive Surgery Devices
  • Navigation & Visualization Systems
  • Others

By Application

  • Cardiology
  • Gastrointestinal
  • Orthopedic
  • Gynecological
  • Neurology
  • Dental
  • Others

By End-user

  • Hospitals & ASCs
  • Clinics
  • Others

By Geography

  • North America (By Type, Application, End-user, and Country)
    • U.S.
    • Canada
  • Europe (By Type, Application, End-user, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (By Type, Application, End-user, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America (By Type, Application, End-user, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, Application, End-user, and Country/Sub-region)
    • GCC
    • South Africa
    • Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Number of Key Surgeries, By Key Countries/Region, 2024
  • 4.2. Key Industry Developments - (Mergers, Acquisition & Partnerships, etc.)
  • 4.3. Overview: Regulatory & Reimbursement Scenario
  • 4.4. New Product Launches, By Key Players

5. Global Minimally Invasive Surgery Devices Market Analysis, Insights and Forecast, 2019-2032

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Inflation Devices
    • 5.1.2. Guiding Devices
    • 5.1.3. Endoscopic Devices
    • 5.1.4. Laparoscopic Devices
    • 5.1.5. Robotic Assistive Surgery Devices
    • 5.1.6. Navigation & Visualization Systems
    • 5.1.7. Others
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Cardiology
    • 5.2.2. Gastrointestinal
    • 5.2.3. Orthopedic
    • 5.2.4. Gynecological
    • 5.2.5. Neurology
    • 5.2.6. Dental
    • 5.2.7. Others
  • 5.3. Market Analysis, Insights and Forecast - By End-user
    • 5.3.1. Hospitals & ASCs
    • 5.3.2. Clinics
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Minimally Invasive Surgery Devices Market Analysis, Insights and Forecast, 2019-2032

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Inflation Devices
    • 6.1.2. Guiding Devices
    • 6.1.3. Endoscopic Devices
    • 6.1.4. Laparoscopic Devices
    • 6.1.5. Robotic Assistive Surgery Devices
    • 6.1.6. Navigation & Visualization Systems
    • 6.1.7. Others
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Cardiology
    • 6.2.2. Gastrointestinal
    • 6.2.3. Orthopedic
    • 6.2.4. Gynecological
    • 6.2.5. Neurology
    • 6.2.6. Dental
    • 6.2.7. Others
  • 6.3. Market Analysis, Insights and Forecast - By End-user
    • 6.3.1. Hospitals & ASCs
    • 6.3.2. Clinics
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Minimally Invasive Surgery Devices Market Analysis, Insights and Forecast, 2019-2032

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Inflation Devices
    • 7.1.2. Guiding Devices
    • 7.1.3. Endoscopic Devices
    • 7.1.4. Laparoscopic Devices
    • 7.1.5. Robotic Assistive Surgery Devices
    • 7.1.6. Navigation & Visualization Systems
    • 7.1.7. Others
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Cardiology
    • 7.2.2. Gastrointestinal
    • 7.2.3. Orthopedic
    • 7.2.4. Gynecological
    • 7.2.5. Neurology
    • 7.2.6. Dental
    • 7.2.7. Others
  • 7.3. Market Analysis, Insights and Forecast - By End-user
    • 7.3.1. Hospitals & ASCs
    • 7.3.2. Clinics
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia pacific Minimally Invasive Surgery Devices Market Analysis, Insights and Forecast, 2019-2032

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Inflation Devices
    • 8.1.2. Guiding Devices
    • 8.1.3. Endoscopic Devices
    • 8.1.4. Laparoscopic Devices
    • 8.1.5. Robotic Assistive Surgery Devices
    • 8.1.6. Navigation & Visualization Systems
    • 8.1.7. Others
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Cardiology
    • 8.2.2. Gastrointestinal
    • 8.2.3. Orthopedic
    • 8.2.4. Gynecological
    • 8.2.5. Neurology
    • 8.2.6. Dental
    • 8.2.7. Others
  • 8.3. Market Analysis, Insights and Forecast - By End-user
    • 8.3.1. Hospitals & ASCs
    • 8.3.2. Clinics
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Minimally Invasive Surgery Devices Market Analysis, Insights and Forecast, 2019-2032

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Inflation Devices
    • 9.1.2. Guiding Devices
    • 9.1.3. Endoscopic Devices
    • 9.1.4. Laparoscopic Devices
    • 9.1.5. Robotic Assistive Surgery Devices
    • 9.1.6. Navigation & Visualization Systems
    • 9.1.7. Others
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Cardiology
    • 9.2.2. Gastrointestinal
    • 9.2.3. Orthopedic
    • 9.2.4. Gynecological
    • 9.2.5. Neurology
    • 9.2.6. Dental
    • 9.2.7. Others
  • 9.3. Market Analysis, Insights and Forecast - By End-user
    • 9.3.1. Hospitals & ASCs
    • 9.3.2. Clinics
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Minimally Invasive Surgery Devices Market Analysis, Insights and Forecast, 2019-2032

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Inflation Devices
    • 10.1.2. Guiding Devices
    • 10.1.3. Endoscopic Devices
    • 10.1.4. Laparoscopic Devices
    • 10.1.5. Robotic Assistive Surgery Devices
    • 10.1.6. Navigation & Visualization Systems
    • 10.1.7. Others
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Cardiology
    • 10.2.2. Gastrointestinal
    • 10.2.3. Orthopedic
    • 10.2.4. Gynecological
    • 10.2.5. Neurology
    • 10.2.6. Dental
    • 10.2.7. Others
  • 10.3. Market Analysis, Insights and Forecast - By End-user
    • 10.3.1. Hospitals & ASCs
    • 10.3.2. Clinics
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2024)
  • 11.2. Company Profiles
    • 11.2.1. Medtronic
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Johnson & Johnson Services, Inc.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Koninklijke Philips N.V.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Boston Scientific Corporation
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Olympus Corporation
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Stryker
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. B. Braun SE
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Steris
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Intuitive Surgical
      • 11.2.9.1. Overview
      • 11.2.9.2. Products
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 2: Global Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 3: Global Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by End-user 2019-2032
  • Table 4: Global Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Region, 2019-2032
  • Table 5: North America Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 6: North America Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 7: North America Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by End-user 2019-2032
  • Table 8: North America Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Country, 2019-2032
  • Table 9: Europe Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 10: Europe Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 11: Europe Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by End-user 2019-2032
  • Table 12: Europe Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Country/Sub-region, 2019-2032
  • Table 13: Asia Pacific Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 14: Asia Pacific Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 15: Asia Pacific Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by End-user 2019-2032
  • Table 16: Asia Pacific Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Country/Sub-region, 2019-2032
  • Table 17: Latin America Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 18: Latin America Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 19: Latin America Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by End-user 2019-2032
  • Table 20: Latin America Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Country/Sub-region, 2019-2032
  • Table 21: Middle East & Africa Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 22: Middle East & Africa Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 23: Middle East & Africa Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by End-user 2019-2032
  • Table 24: Middle East & Africa Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Country/Sub-region, 2019-2032

List of Figures

  • Figure 1: Global Minimally Invasive Surgery Devices Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032
  • Figure 2: Global Minimally Invasive Surgery Devices Market Value Share (%), by Type, 2024 & 2032
  • Figure 3: Global Minimally Invasive Surgery Devices Market Value Share (%), by Application, 2024 & 2032
  • Figure 4: Global Minimally Invasive Surgery Devices Market Value Share (%), by End-user, 2024 & 2032
  • Figure 5: Global Minimally Invasive Surgery Devices Market Value (USD billion), by Region, 2024 & 2032
  • Figure 6: North America Minimally Invasive Surgery Devices Market Value (USD billion), by Type, 2024 & 2032
  • Figure 7: North America Minimally Invasive Surgery Devices Market Value Share (%), by Type, 2024
  • Figure 8: North America Minimally Invasive Surgery Devices Market Value (USD billion), by Application, 2024 & 2032
  • Figure 9: North America Minimally Invasive Surgery Devices Market Value Share (%), by Application, 2024
  • Figure 10: North America Minimally Invasive Surgery Devices Market Value (USD billion), by End-user, 2024 & 2032
  • Figure 11: North America Minimally Invasive Surgery Devices Market Value Share (%), by End-user, 2024
  • Figure 12: North America Minimally Invasive Surgery Devices Market Value (USD billion), By Country, 2024 & 2032
  • Figure 13: North America Minimally Invasive Surgery Devices Market Value Share (%), By Country, 2024
  • Figure 14: Europe Minimally Invasive Surgery Devices Market Value (USD billion), by Type, 2024 & 2032
  • Figure 15: Europe Minimally Invasive Surgery Devices Market Value Share (%), by Type, 2024
  • Figure 16: Europe Minimally Invasive Surgery Devices Market Value (USD billion), by Application, 2024 & 2032
  • Figure 17: Europe Minimally Invasive Surgery Devices Market Value Share (%), by Application, 2024
  • Figure 18: Europe Minimally Invasive Surgery Devices Market Value (USD billion), by End-user, 2024 & 2032
  • Figure 19: Europe Minimally Invasive Surgery Devices Market Value Share (%), by End-user, 2024
  • Figure 20: Europe Minimally Invasive Surgery Devices Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 21: Europe Minimally Invasive Surgery Devices Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 22: Asia Pacific Minimally Invasive Surgery Devices Market Value (USD billion), by Type, 2024 & 2032
  • Figure 23: Asia Pacific Minimally Invasive Surgery Devices Market Value Share (%), by Type, 2024
  • Figure 24: Asia Pacific Minimally Invasive Surgery Devices Market Value (USD billion), by Application, 2024 & 2032
  • Figure 25: Asia Pacific Minimally Invasive Surgery Devices Market Value Share (%), by Application, 2024
  • Figure 26: Asia Pacific Minimally Invasive Surgery Devices Market Value (USD billion), by End-user, 2024 & 2032
  • Figure 27: Asia Pacific Minimally Invasive Surgery Devices Market Value Share (%), by End-user, 2024
  • Figure 28: Asia Pacific Minimally Invasive Surgery Devices Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 29: Asia Pacific Minimally Invasive Surgery Devices Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 30: Latin America Minimally Invasive Surgery Devices Market Value (USD billion), by Type, 2024 & 2032
  • Figure 31: Latin America Minimally Invasive Surgery Devices Market Value Share (%), by Type, 2024
  • Figure 32: Latin America Minimally Invasive Surgery Devices Market Value (USD billion), by Application, 2024 & 2032
  • Figure 33: Latin America Minimally Invasive Surgery Devices Market Value Share (%), by Application, 2024
  • Figure 34: Latin America Minimally Invasive Surgery Devices Market Value (USD billion), by End-user, 2024 & 2032
  • Figure 35: Latin America Minimally Invasive Surgery Devices Market Value Share (%), by End-user, 2024
  • Figure 36: Latin America Minimally Invasive Surgery Devices Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 37: Latin America Minimally Invasive Surgery Devices Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 38: Middle East & Africa Minimally Invasive Surgery Devices Market Value (USD billion), by Type, 2024 & 2032
  • Figure 39: Middle East & Africa Minimally Invasive Surgery Devices Market Value Share (%), by Type, 2024
  • Figure 40: Middle East & Africa Minimally Invasive Surgery Devices Market Value (USD billion), by Application, 2024 & 2032
  • Figure 41: Middle East & Africa Minimally Invasive Surgery Devices Market Value Share (%), by Application, 2024
  • Figure 42: Middle East & Africa Minimally Invasive Surgery Devices Market Value (USD billion), by End-user, 2024 & 2032
  • Figure 43: Middle East & Africa Minimally Invasive Surgery Devices Market Value Share (%), by End-user, 2024
  • Figure 44: Middle East & Africa Minimally Invasive Surgery Devices Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 45: Middle East & Africa Minimally Invasive Surgery Devices Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 46: Global Minimally Invasive Surgery Devices Market Share (%), By Company, 2024